HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yedid Elbez Selected Research

Coronary Disease (Coronary Heart Disease)

10/2022Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yedid Elbez Research Topics

Disease

9Rheumatoid Arthritis
01/2023 - 01/2016
9Myocardial Infarction
01/2023 - 11/2014
8Thrombosis (Thrombus)
01/2023 - 08/2014
8Acute Coronary Syndrome
01/2023 - 11/2017
7Stroke (Strokes)
01/2023 - 11/2014
6Hemorrhage
01/2021 - 10/2017
5Coronary Artery Disease (Coronary Atherosclerosis)
08/2023 - 01/2016
4ST Elevation Myocardial Infarction
03/2021 - 11/2017
3Cardiovascular Diseases (Cardiovascular Disease)
10/2021 - 10/2015
3Heart Failure
10/2020 - 09/2017
2Non-ST Elevated Myocardial Infarction
01/2023 - 11/2017
2Unstable Angina
10/2022 - 10/2021
2Ischemic Stroke
10/2022 - 01/2018
2Psoriatic Arthritis
07/2020 - 01/2019
2Vascular Diseases (Vascular Disease)
01/2019 - 09/2017
2Rheumatic Diseases (Rheumatism)
01/2017 - 01/2016
1Diabetes Mellitus
01/2023
1Pathologic Constriction (Stenosis)
01/2023
1Type 2 Diabetes Mellitus (MODY)
01/2023
1Coronary Disease (Coronary Heart Disease)
10/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
02/2022
1Synovitis
01/2022
1Pain (Aches)
01/2022
1Edema (Dropsy)
01/2022
1Inflammation (Inflammations)
01/2022
1Hypertriglyceridemia
10/2021
1Overweight
01/2019
1Chronic Renal Insufficiency
01/2018
1Renal Insufficiency (Renal Failure)
01/2018
1Atrial Fibrillation
10/2017
1Atherosclerosis
09/2017
1Hypercholesterolemia
02/2016
1Peripheral Arterial Disease
11/2014

Drug/Important Bio-Agent (IBA)

10Abatacept (Orencia)FDA Link
01/2023 - 01/2016
7otamixabanIBA
01/2023 - 11/2017
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2023 - 02/2016
5Troleandomycin (TAO)FDA Link
01/2023 - 11/2017
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2021 - 08/2014
5Heparin (Liquaemin)FDA LinkGeneric
03/2021 - 11/2017
4Eptifibatide (Integrilin)FDA Link
03/2021 - 11/2017
2omega-Chloroacetophenone (Mace)IBA
10/2022 - 10/2017
2Glycoproteins (Glycoprotein)IBA
01/2018 - 01/2018
1CoffeeFDA Link
08/2023
1TeaIBA
08/2023
1TicagrelorIBA
01/2023
1LDL CholesterolIBA
01/2023
1alirocumabIBA
10/2022
1TYK2 Kinase (Tyrosine Kinase 2)IBA
02/2022
1deucravacitinibIBA
02/2022
1ametantrone (HAQ)IBA
01/2022
1Triglycerides (Triacylglycerol)IBA
10/2021
1eicosapentaenoic acid ethyl esterIBA
10/2021
1Anti-Citrullinated Protein AntibodiesIBA
05/2020
1Tumor Necrosis Factor InhibitorsIBA
05/2020
1RivaroxabanIBA
01/2019
1Methotrexate (Mexate)FDA LinkGeneric
01/2018
1AnticoagulantsIBA
01/2018
1bivalirudin (Angiomax)FDA Link
01/2018
1APTIBA
10/2017
1Vitamin KFDA Link
10/2017
1GlucocorticoidsIBA
01/2016

Therapy/Procedure

6Percutaneous Coronary Intervention
01/2023 - 01/2018
5Therapeutics
10/2021 - 11/2014
4Stents
10/2020 - 01/2018
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2023 - 01/2018
1Myocardial Revascularization
01/2016
1Surgical Amputation (Amputations)
11/2014